<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>JAY-PHYL - dyphylline and guaifenesin syrup </strong><br>JayMac Pharmaceuticals LLC<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>Jay-Phyl Syrup</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1>Jay-Phyl Syrup</h1>
<span class="Bold">Bronchodilator/Expectorant</span><br><span class="Bold">Rx Only</span><br><br><span class="Bold">DESCRIPTION:<br></span>Jay-Phyl Syrup is a bronchodilator/expectorant combination supplied as a Orange, Vanilla flavored, <br>alcohol free and gluten free liquid for oral administration.<br><br>Each teaspoonful (5 mL) contains:<br>Dyphylline........... 100 mg<br>Guaifenesin........... 50 mg<br><br><span class="Bold">Inactive ingredients:</span> Glycerin, Propylene Glycol, Sorbitol, Citric Acid, Sodium Citrate, Sodium <br>Saccharin, Vanilla Flavor, FD and C Yellow No. 6, Purified Water.<br><br>Dyphylline is 7-(2,3-dihydroxypropyl)-theophylline, a white, extremely bitter, amorphous powder that is fully <br>soluble in water and soluble in alcohol to the extent of 2 g/100 mL. Dyphylline forms a neutral solution that <br>is stable in gastrointestinal fluids over a wide range of pH. It has the following chemical structure:<br><br><div class="Figure"><img alt="Dyphylline Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=d35db38b-8b0e-4872-ab18-09795c5e07e9&amp;name=MM2.jpg"></div>
<br><br>Guaifenesin is an expectorant which occurs as a white to slightly gray, crystalline powder, having a bitter <br>taste. It may have a slight characteristic odor. It is soluble in water, alcohol, chloroform, glycerin, and <br>propylene glycol. The chemical name is 1,2-Propanediol, 3-(2-methoxyphenoxy)-, (±)-. It has the following <br>chemical structure:<br><div class="Figure"><img alt="Guaifenesin Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=d35db38b-8b0e-4872-ab18-09795c5e07e9&amp;name=MM3.jpg"></div>
<br>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>Dyphylline is a xanthine derivative with pharmacological actions similar to theophylline and other <br>members of this class of drugs. Its primary action is that of bronchodilation, but it also exhibits <br>peripheral vasodilatory and other smooth muscle relaxant activity to a lesser degree. The <br>bronchodilatory action of dyphylline, as with other xanthines, is thought to be mediated through <br>competitive inhibition of phosphodiesterase with a resulting increase in cyclic AMP producing <br>relaxation of bronchial smooth muscle.<br><br>Dyphylline was reported to be the least toxic of seven theophylline derivatives, including the piperazine, <br>N, N-diethylamino ethyl and the 2-hydroxy ethyl derivatives. The toxicity of dyphylline is only one-fifth <br>that of aminophylline as determined intraperitoneally in mice, and only one-half as toxic in rats. Unlike <br>the hydrolysable salts of theophylline, dyphylline is not converted to free theophylline in vivo. It is <br>absorbed rapidly in therapeutically active form and in healthy volunteers reaches a mean peak plasma <br>concentraion of 17.1 mcg/mL in approximately 45 minutes following a single oral dose of 1000 mg of <br>dyphylline.<br><br>Dyphylline exerts its bronchodilatory effects directly and, unlike theophylline, is excreted unchanged <br>by the kidneys without being metabolized by the liver. Because of this, dyphylline pharmacokinetics <br>and plasma levels are not influenced by various factors that affect liver function and hepatic enzyme <br>activity, such as smoking, age, or concomitant use of drugs which affect liver function.<br><br>The elimination half-life of dyphylline is approximately two hours (1.8-2.1 hr) and approximately 88% <br>of a single oral dose can be recovered from the urine unchanged. The renal clearance would be <br>correspondingly reduced in patients with impaired function. In anuric patients, the half-life may be <br>increased 3 to 4 times normal. Dyphylline plasma levels are dose-related and generally predictable. <br>The therapeutic range of plasma levels within which dyphylline can be expected to produce effective <br>bronchodilation has not been determined.<br><br>Dyphylline plasma concentrations can be accurately determined using high pressure liquid <br>chromatography (HPLC) or gas-liquid chromatography (GLC). Guaifenesin is an expectorant whose <br>action helps increase the output of thin respiratory tract fluid to facilitate mucociliary clearance and <br>removal of inspissated mucus. <br><br>Guaifenesin is an expectorant which increases respiratory tract fluid secretions and helps to loosen <br><span class="product-label-link" type="condition" conceptid="4102774" conceptname="Productive cough">phlegm</span> and bronchial secretions. By reducing the viscosity of secretions, guaifenesin increases the <br>efficiency of the <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">cough</span> reflex and of ciliary action in removing accumulated secretions from the trachea <br>and bronchi. Guaifenesin is readily absorbed from the gastrointestinal tract and is rapidly metabolized <br>and excreted in the urine. Guaifenesin has a plasma half-life of one hour. The major urinary metabolite <br>is p-(2-methoxyphenoxy) lactic acid.<br>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE:</h1>Jay-Phyl Syrup is indicated as a bronchodilator-expectorant for treating bronchial <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, <br><span class="product-label-link" type="condition" conceptid="4169883" conceptname="Emphysema">emphysema</span>, <span class="product-label-link" type="condition" conceptid="256451" conceptname="Bronchitis">bronchitis</span>, <span class="product-label-link" type="condition" conceptid="253506" conceptname="Pneumonitis">pneumonitis</span> and other related bronchopulmonary insufficiency conditions. <br>Jay-Phyl Syrup acts to dilate bronchioles and liquefy mucus, giving relief from <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span>, <br>non-<span class="product-label-link" type="condition" conceptid="4102774" conceptname="Productive cough">productive cough</span> and tracheobronchial irritation.<br>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS:</h1>As with other theophylline-type drugs, combining dyphylline with epehdrine or other sympathomimetic <br>drugs can cause excessive CNS stimulation. Such combinations are contraindicated in children unless <br>accompanied by sufficient sedation to prevent undue CNS stimulation.<br>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-5"></a><p></p>
<h1>WARNINGS</h1>This product is not indicated in the management of status asthmaticus, which is a serious <br>medical emergency.<br><br>Although the relationship between plasma levels of dyphylline and appearance of toxicity is <br>unknown, excessive doses may be expected to be associated with an increased risk of <br>adverse effects.<br>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<h1>PRECAUTIONS:</h1>
<span class="Bold">General:</span> Use this product with caution in patients with severe cardiac disease, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, <br><span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, <span class="product-label-link" type="condition" conceptid="140673" conceptname="Hypothyroidism">hypothyroidism</span>, severe renal and <span class="product-label-link" type="condition" conceptid="4212540" conceptname="Chronic liver disease">hepatic disease</span>, acute myocardial injury or peptic <br><span class="product-label-link" type="condition" conceptid="4177703" conceptname="Ulcer">ulcer</span>. Do not use in children under age six. Do not exceed 3 mg of dyphylline per pound <br>of body weight daily in older children. Because the xanthines also act as diuretics, special <br>precaution regarding hydration and avoidance of <span class="product-label-link" type="condition" conceptid="435517" conceptname="Acidosis">acidosis</span> should be observed in children. The <br>long term use of xanthine derivatives may result in a cumulative effect with increase in adverse <br>reactions, as well as the development of tolerance.<br>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-7"></a><p></p>
<h1>Drug Interactions:</h1>Synergism between xanthine bronchodilators (e.g., theophylline), ephedrine and other sympathomimetic <br>bronchodilators has been reported. This should be considered whenever these agents are prescribed <br>concomitantly. Concurrent administration of dyphylline and probenecid, which competes for tubular secretion, <br>has been shown to increase plasma half-life and dyphylline (See Clinical Pharmacology).<br>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-8"></a><p></p>
<h1>Carcinogenesis, Mutagenesis, Impairment of Fertility:</h1>No long-term animal studies have been performed with this product.<br>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-9"></a><p></p>
<h1>Pregnancy: Teratogenic effects- Pregnancy Category C.</h1>Animal reproduction studies have not been conducted with this formulation. It is also not known whether <br>this product can cause fetal harm when administered to a pregnant woman or can affect reproduction <br>capacity. This medication should be given to a pregnant woman only if clearly needed.<br>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-10"></a><p></p>
<h1>Nursing Mothers:</h1>Dyphylline is present in human milk at approximately twice the maternal plasma concentration. <br>Caution should be exercised when this product is administered to a nursing woman.<br>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-11"></a><p></p>
<h1>Pediatric Use:</h1>Safety and effectiveness in children below the age of six have not been established. <br>Use caution when administering to children six years of age or older.<br>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-12"></a><p></p>
<h1>ADVERSE REACTIONS</h1>This formulation may cause <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, cardiac <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitation</span> and CNS stimulation.<br><br>Postprandial administration may help avoid gastric <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span>.<br><br>The following adverse reactions which have been reported with other xanthine bronchodilators, <br>and which have most often been related to excessive drug plasma levels, should be considered <br>as potential adverse effects when dyphylline is administered.<br><br><span class="Bold">Gastrointestinal:</span> <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="194175" conceptname="Left upper quadrant pain">epigastric pain</span>, <span class="product-label-link" type="condition" conceptid="26727" conceptname="Hematemesis">hematemesis</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>.<br><span class="Bold"><br>Central Nervous System:</span> <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">hyperexcitability</span>, <br><span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>, <span class="product-label-link" type="condition" conceptid="4247265" conceptname="Muscle twitch">muscle twitching</span>, generalized clonic and <span class="product-label-link" type="condition" conceptid="4198075" conceptname="Tonic seizure">tonic convulsions</span>.<br><br><span class="Bold">Cardiovascular:</span> <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitation</span>, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="316429" conceptname="Premature beats">extrasystoles</span>, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">circulatory failure</span>, <br><span class="product-label-link" type="condition" conceptid="4185572" conceptname="Ventricular arrhythmia">ventricular arrhythmias</span>.<br><span class="Bold"><br></span><span class="Bold"><span class="Bold">Respiratory:</span> <span class="product-label-link" type="condition" conceptid="317376" conceptname="Tachypnea">tachypnea</span>.<br><br>Renal:</span> <span class="product-label-link" type="condition" conceptid="4168705" conceptname="Albuminuria">albuminuria</span>, gross and <span class="product-label-link" type="condition" conceptid="75004" conceptname="Frank hematuria">microscopic hematuria</span>, <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">diuresis</span>.<br><span class="Bold"><br>Other:</span> <span class="product-label-link" type="condition" conceptid="4214376" conceptname="Hyperglycemia">hyperglycemia</span>, <span class="product-label-link" type="condition" conceptid="4207539" conceptname="Syndrome of inappropriate vasopressin secretion">inappropriate ADH</span> syndrome.<br><br>Large doses of Guaifenesin may produce <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span>, but <span class="product-label-link" type="condition" conceptid="4183041" conceptname="Abdominal discomfort">gastrointestinal upset</span> at ordinary dosage <br>levels is rare.<br>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-13"></a><p></p>
<h1>OVERDOSAGE</h1>
<span class="Bold">Signs and Symptoms:</span> <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">Restlessness</span>, <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>, <br>and <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span> are typical symptoms resulting from a xanthine drug <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>. Marked overdosage <br>with resulting severe toxicity has produced <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>, severe <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span>, <span class="product-label-link" type="condition" conceptid="4241197" conceptname="Thirst">excessive thirst</span>, <br><span class="product-label-link" type="condition" conceptid="377575" conceptname="Tinnitus">tinnitus</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>, <span class="product-label-link" type="condition" conceptid="4178904" conceptname="Body temperature above reference range">hyperthermia</span>, <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">diaphoresis</span>, and generalized clonic and tonic <br><span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>. <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">Cardiovascular collapse</span> has also occurred, with some fatalities. <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">Seizures</span> have <br>occured in some cases associated with very high theophylline plasma concentrations, without <br>any premonitory symptoms of toxicity.<br><span class="Bold"><br>Treatment:</span> There is no specific antidote for overdosage with drugs of the xanthine class. <br>Symptomatic treatment and general supportive measures should be instituted with careful <br>monitoring and maintenance of vital signs, fluids and electrolytes. The stomach should be <br>emptied by inducing <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span> if the patient is conscious and responsive, or by gastric lavage, <br>taking care to protect against <span class="product-label-link" type="condition" conceptid="4239038" conceptname="Pulmonary aspiration">aspiration</span>, especially in stuporous or <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">comatose</span> patients. <br>Maintenance of an adequate airway is essential in case oxygen or assisted respiration is needed. <br>Sympathomimetic agents should be avoided but sedatives such as short acting barbiturates may <br>be useful.<br><br>Dypyhlline is dialyzable and although not recommended as routine procedure in overdosage cases, <br>hemodialysis may be of some benefit with severe <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> is present or when the patient has <br>not responded to general supportive and symptomatic treatment.<br>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-14"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:</h1>The usual adult dose is 1 or 2 teaspoonfuls of liquid 3 or 4 times a day. In severe cases, dosage may <br>be doubled or tripled if necessary. Maintenance dosage should be adjusted according to patient response. <br><br><span class="Bold">Use in Children:</span><br>Altough pediatric dosages of dyphylline are established, no firm dosage for a combination of dyphylline <br>and guaifenesin USP can be recommended for children under the age of six. Dosage for children over <br>six may be calculated on the basis of 2 to 3 mg of dyphylline per pound of body weight daily in divided doses.<br>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-15"></a><p></p>
<h1>HOW SUPPLIED:</h1>Jay-Phyl Syrup is supplied as a orange, vanilla flavored, alcohol free and gluten free liquid in pint <br>bottles, NDC 64661-0814-16 and in 15 mL bottles, NDC 64661-0814-15.<br><br><span class="Bold">Rx Only<br></span><span class="Bold"><br>WARNING: KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. </span><br><span class="Bold">IN CASE OF ACCIDENTAL <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">OVERDOSE</span>, SEEK PROFESSIONAL ASSISTANCE OR </span><br><span class="Bold">CONTACT A POISON CONTROL CENTER IMMEDIATELY.</span><br>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="section-16"></a><p></p>
<h1>STORAGE:</h1>Store at controlled room temperature 15<span class="Sup">o</span>-30<span class="Sup">o</span>C (59<span class="Sup">o</span>-86<span class="Sup">o</span>F).<br><br>Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.<br><br>Manufactured by:<br>Great Southern Laboratories<br>Houston, TX 77099<br><br>Manufactured for:<br>JayMac Pharmaceuticals, Inc.<br>Sunset, LA 70584<br><br>Rev. 10/08<br>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-17"></a><p></p>
<h1>PRODUCT PACKAGING:</h1>The packaging below represents the labeling currently used:<br><br><span class="Bold">Principal Display Panel and Side Panel for 15 mL Label:</span><br><span class="Bold"><br>NDC 64661-814-15</span><br><br><span class="Bold">Jay-Phyl Syrup</span><br><br><span class="Bold">Each 5 mL contains:</span><br><span class="Bold">Dyphylline............. 100 mg</span><br><span class="Bold">Guaifenesin........... 50 mg</span><br><br><span class="Bold">Sugar and Alcohol Free<br></span><br><span class="Bold">Rx Only</span><br><br><span class="Bold">1/2 fl oz (15 mL)</span><br><br><span class="Bold">DOSAGE AND ADMINISTRATION:</span><br><span class="Bold">Adults:</span> 2 teaspoonfuls (10 mL) 3 or 4 times daily. Children 6 to 12 should be started on low doses <br>which are gradually increased to the lowest effective dose, not to exceed 10mg/kg/day in divided <br>doses. Not recommended for pediatric patients under 6 years.<br><br>See package insert for full prescribing information.<br><br>Store at controlled room temperature, 15<span class="Sup">o</span>-30<span class="Sup">o</span>C (59<span class="Sup">o</span>-86<span class="Sup">o</span>F).<br><br>Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.<br><br><span class="Bold">KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.</span><br><span class="Bold">IN CASE OF ACCIDENTAL <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">OVERDOSE</span>, CONTACT A POISON CONTROL </span><br><span class="Bold">CENTER AND SEEK PROFESSIONAL ASSISTANCE IMMEDIATELY.</span><br><span class="Bold"><br>Manufactured for:</span><br>JayMac Pharmaceuticals<br>Sunset, LA 70584                 Rev. 11/07<br><br><span class="Bold">PROFESSIONAL SAMPLE</span><br><span class="Bold">NOT FOR RESALE<br><br></span><br><div class="Figure"><img alt="Jay-Phyl Packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=d35db38b-8b0e-4872-ab18-09795c5e07e9&amp;name=MM1.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>JAY-PHYL 		
					</strong><br><span class="contentTableReg">dyphylline and guaifenesin syrup</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:64661-814</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Dyphylline</strong> (Dyphylline) </td>
<td class="formItem">Dyphylline</td>
<td class="formItem">100 mg  in 5 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>Guaifenesin</strong> (Guaifenesin) </td>
<td class="formItem">Guaifenesin</td>
<td class="formItem">50 mg  in 5 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Glycerin</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Propylene Glycol</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Sorbitol</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Citric Acid</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Sodium Citrate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Saccharin Sodium</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Water</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">    </td>
<td class="formLabel">Score</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem">VANILLA</td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:64661-814-15</td>
<td class="formItem">15 mL in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">05/02/2006</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>JayMac Pharmaceuticals LLC
							(830767260)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Great Southern Laboratories (056139553)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Great Southern Laboratories</td>
<td class="formItem"></td>
<td class="formItem">056139553</td>
<td class="formItem">manufacture</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 8/2010<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>6c7d859f-7247-46bf-877c-d98b77e22f50</div>
<div>Set id: d35db38b-8b0e-4872-ab18-09795c5e07e9</div>
<div>Version: 2</div>
<div>Effective Time: 20100825</div>
</div>
</div> <div class="DistributorName">JayMac Pharmaceuticals LLC</div></p>
</body></html>
